EBQ:CRASH-2 Trial

Revision as of 02:52, 5 January 2014 by Ostermayer (talk | contribs)

{{info | title=Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage | abbreviation=CRASH-2 | expansion=Clinical Randomisation of an Antifibrinolytic in Significant Hemorrhage 2 | published=2010-07 | author=Shakur H, et al | journal=The Lancet | year=2010 | volume=376 | issue=9734 | pages=23-32 | pmid=20554319 | fulltexturl=http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2810%2960835-5/fulltext | pdfurl=http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610608355.pdf

Clinical Question

Conclusion

Major Points

Study Design

Inclusion Criteria

Exclusion Criteria

Interventions

Outcome

Primary Outcomes

Secondary Outcomes

Subgroup analysis

Criticisms & Further Discussion

Funding

Sources